Table 1 Clinical characteristics of female RA and stroke cohorts

n

96

88

66

66

Age, years

59.0 [51.2–63]

47.5 ^{p < 0.0001} [34.5–55.3]

58.5 ^p = 0.73 [51–66]

52.7 ^{p = 0.004} [39.8–61.7]

Serum IGF1, ng/ml

109.5 [93–127]

182.5 ^{p < 0.0001} [158–225]

111.6 ^p = 0.74 [92–127]

183 ^{p < 0.0001} [167–223]

Height, cm

166 [161–169]

167 ^{p = 0.041} [163–172]

163 ^{p = 0.005} [160–167]

167 ^{p = 0.009} [161–172]

Systolic BP, mmHg

135 [120–145]

121 ^{p = 0.0027} [120–140]

135 ^p = 0.70 [120–140]

130 ^{p = 0.114}[120–140]

Diastolic BP, mmHg

80 [75–85]

80 ^{p = 0.023} [70–80]

80 ^{p = 0.037} [70–80]

75 ^{p = 0.058} [70–80]

TC, mmol/L

5.6 [4.9–6.0]

5.0 ^{p = 0.0022} [4.1–5.9]

5.1 ^{p = 0.0004} [4.5–5.8]

4.8 ^{p = 0.063} [4.3–5.5]

LDL, mmol/L

3.4 [2.8–4.0]

3.0 ^p = 0.17 [2.3–3.8]

2.8 ^{p < 0.0001} [2.1–3.50]

2.6 ^p = 0.89 [2.30–3.30]

HDL, mmol/L

1.8 [1.5–2.2]

1.7 ^p = 0.20 [1.5–2.1]

1.6 ^{p = 0.0002} [1.30–1.90]

1.5 ^p = 0.13 [1.10–1.80]

BMI, kg/m²

25.9 [23.1–29.7]

23.9 ^{p = 0.0014} [21.9–26.7]

24.0 ^p = 0.17 [21.8–28.3]

24.6 ^p = 0.94 [22.5–28.0]

T2D, n (%)

2 (2.1%)

4 ^p = 0.39 (4.5%)

12 ^{p = 0.0004} (19%)

7 ^p = 0.23 (9%)

Current smokers, n (%)

15 (16%)

13 ^p = 0.88 (16%)

32 ^{p < 0.001} (48%)

28 ^p = 0.49 (45%)

Hypertension*, n (%)

25 (26%)

7 ^{p = 0.011} (8%)

30 ^{p = 0.012} (45%)

28 ^p = 0.17 (42%)